LLY
$LLY
Eli Lilly and Company
Pharmaceutical heavyweight known for weight-loss drugs Mounjaro and Zepbound.
Healthcare$1036.05
-3.95 (-0.38%)
Day Range$1034.88 - $1067.00
Prev Close$1040.00
Analyst Rating
Strong Buy
27 Buy / 10 Hold / 0 Sell
Subscribers
2
Tracking this ticker
Next Report
Sun, Feb 22
Weekly updates
Latest Report
LLY: GLP-1 Growth, AI Bets, and Durable Moat
Eli Lilly ($LLY) remains a top-growth pharma name thanks to blockbuster GLP-1 sales, a $1.5bn pre-launch inventory strategy and an AI push for drug discovery. Valuation is rich but the risk/reward looks attractive for long-term investors.
Feb 17, 2026